SOPHARMA AD: Sopharma monthly November 2016

opublikowano: 2016-12-05 15:05

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
Sopharma_monthly_November_2016.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 104 / 2016
Date of issue: 2016-12-05
Short name of the issuer
SOPHARMA AD
Subject
Sopharma monthly November 2016
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
For the first eleven months of this year, revenues from sales decreased by 5% compared to the same period of 2015, including 2% increase of domestic sales and 10% decrease of export sales. “The Russian market remains uncertain, which does not allow us to make forecasts for the year-end sales results, but we managed to limit the decrease of sales revenues in the second half of 2016.”, states Ognian Donev, PhD, Executive Director and Chairman of the Board of Directors of Sopharma AD.
Annexes
File Description
Sopharma monthly November 2016.docSopharma monthly November 2016.doc Sopharma monthly November 2016

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2016-12-05 Ognian Donev Executive director